Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy
Cancer Research and Treatment. 1970;47(1):26-33 
P69 Sentinel lymph node biopsy is feasible for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy
The Breast. 2007;16:S32
Sentinel lymph node biopsy in patients who had conversion of axillary lymph nodes from clinically positive to negative following neoadjuvant chemotherapy
European Journal of Cancer. 2018;92:S79
Sentinel Lymph Node Biopsy in Patients with Clinically Negative Lymph Node After Neoadjuvant Chemotherapy
Journal of Breast Cancer. 2007;10(4):254
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation
Breast Diseases: A Year Book Quarterly. 2009;20(1):76-77
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
Breast Cancer Research and Treatment. 2021;187(3):915-916
Feasibility of extended sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer patients
European Journal of Cancer. 2017;72:S33
Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
Journal of Breast Cancer. 2021;24(6):531
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
Breast Cancer Research and Treatment. 2020;186(2):527-534
Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy
The American Journal of Surgery. 2006;191(2):225-229